New York State Common Retirement Fund Syndax Pharmaceuticals Inc Transaction History

New York State Common Retirement Fund

$74.6 Billion
Q4 2024

A detailed history of New York State Common Retirement Fund transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 25,384 shares of SNDX stock, worth $415,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,384

Previous 25,384 -0.0%

Holding current value

$415,789

Previous $489,000 31.29%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$17.93 - $24.81 $353,472 - $489,104	-19,714 Reduced 43.71%	25,384 $489,000
Q2 2024 Jul 31, 2024	SELL	$18.82 - $23.79 $46,617 - $58,927	-2,477 Reduced 5.21%	45,098 $926,000
Q1 2024 May 07, 2024	BUY	$19.71 - $24.57 $366,448 - $456,805	18,592 Added 64.15%	47,575 $1.13 Million
Q4 2023 Feb 01, 2024	SELL	$11.39 - $21.67 $20,980 - $39,916	-1,842 Reduced 5.98%	28,983 $626,000
Q3 2023 Nov 07, 2023	BUY	$14.52 - $21.77 $15,681 - $23,511	1,080 Added 3.63%	30,825 $448,000
Q2 2023 Aug 07, 2023	BUY	$19.35 - $22.31 $1,161 - $1,338	60 Added 0.2%	29,745 $623,000
Q1 2023 May 02, 2023	SELL	$20.66 - $28.98 $158,854 - $222,827	-7,689 Reduced 20.57%	29,685 $627,000
Q4 2022 Jan 30, 2023	BUY	$20.64 - $26.24 $247 - $314	12 Added 0.03%	37,374 $951,000
Q3 2022 Nov 08, 2022	BUY	$18.51 - $24.79 $40,981 - $54,885	2,214 Added 6.3%	37,362 $898,000
Q2 2022 Aug 04, 2022	BUY	$13.64 - $19.48 $37,564 - $53,647	2,754 Added 8.5%	35,148 $676,000
Q1 2022 May 05, 2022	BUY	$14.84 - $22.15 $341 - $509	23 Added 0.07%	32,394 $563,000
Q4 2021 Feb 02, 2022	SELL	$15.23 - $22.47 $1,431 - $2,112	-94 Reduced 0.29%	32,371 $709,000
Q3 2021 Nov 02, 2021	SELL	$13.87 - $19.8 $87,186 - $124,462	-6,286 Reduced 16.22%	32,465 $620,000
Q2 2021 Aug 02, 2021	BUY	$13.42 - $25.18 $188,564 - $353,804	14,051 Added 56.89%	38,751 $665,000
Q2 2020 Aug 07, 2020	BUY	$8.94 - $20.98 $59,004 - $138,468	6,600 Added 36.46%	24,700 $366,000
Q4 2019 Feb 05, 2020	SELL	$5.43 - $9.22 $13,032 - $22,128	-2,400 Reduced 11.71%	18,100 $159,000
Q2 2019 Aug 09, 2019	BUY	$4.9 - $9.31 $54,390 - $103,341	11,100 Added 118.09%	20,500 $191,000
Q2 2017 Aug 11, 2017	BUY	N/A	9,400	9,400 $131,000

Others Institutions Holding SNDX

# of Institutions

232

Shares Held

96.9M

Call Options Held

1.39M

Put Options Held

543K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $927M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Syndax Pharmaceuticals Inc Transaction History